Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Breast (All Stages^), 2020

All Races (includes Hispanic), Female, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 119.2 (118.7, 119.7) N/A 239,612 rising rising trend 0.5 (0.3, 0.7)
Connecticut 7 133.2 (128.4, 138.2) 1 (1, 15) 3,175 rising rising trend 0.3 (0.1, 0.6)
Minnesota 2 132.4 (128.4, 136.5) 2 (1, 13) 4,535 rising rising trend 0.7 (0.4, 1.7)
Hawaii 7 132.3 (124.5, 140.5) 3 (1, 29) 1,200 rising rising trend 1.6 (1.0, 2.9)
Idaho 7 130.6 (123.5, 137.9) 4 (1, 30) 1,406 rising rising trend 0.9 (0.5, 1.8)
New Hampshire 2 130.4 (122.7, 138.4) 5 (1, 32) 1,224 stable stable trend 0.5 (-0.1, 1.0)
North Carolina 2 129.9 (127.1, 132.8) 6 (1, 15) 8,911 rising rising trend 0.9 (0.7, 1.1)
Maryland 2 128.6 (124.9, 132.3) 7 (1, 23) 5,025 stable stable trend 0.4 (0.0, 0.8)
Iowa 7 128.3 (123.1, 133.7) 8 (1, 29) 2,533 rising rising trend 2.5 (0.7, 5.0)
New Jersey 7 127.6 (124.5, 130.6) 9 (2, 22) 7,351 rising rising trend 0.6 (0.4, 0.9)
Vermont 2 127.5 (116.3, 139.5) 10 (1, 45) 549 stable stable trend 0.1 (-0.4, 0.6)
Rhode Island 2 126.5 (117.9, 135.7) 11 (1, 41) 888 rising rising trend 0.7 (0.2, 1.2)
Wisconsin 2 126.3 (122.5, 130.2) 12 (2, 28) 4,692 rising rising trend 0.9 (0.7, 1.2)
Delaware 2 126.0 (117.2, 135.2) 13 (1, 43) 881 rising rising trend 0.8 (0.1, 1.6)
Georgia 7 125.8 (123.0, 128.6) 14 (5, 26) 8,181 rising rising trend 0.6 (0.4, 1.2)
Kansas 2 124.9 (119.5, 130.4) 15 (2, 37) 2,215 rising rising trend 1.8 (0.4, 4.0)
New York 7 124.7 (122.6, 126.7) 16 (8, 27) 15,606 rising rising trend 0.7 (0.5, 1.1)
Massachusetts 7 124.6 (121.2, 128.1) 17 (6, 31) 5,570 rising rising trend 0.3 (0.1, 0.8)
Illinois 7 124.1 (121.5, 126.6) 18 (8, 30) 9,839 rising rising trend 0.7 (0.4, 1.1)
Washington 4 124.0 (120.7, 127.4) 19 (7, 32) 5,739 stable stable trend 0.2 (-0.1, 1.2)
Nebraska 2 123.8 (117.2, 130.8) 20 (2, 41) 1,407 rising rising trend 1.7 (0.1, 4.6)
Missouri 2 123.5 (119.9, 127.2) 21 (6, 34) 4,913 rising rising trend 0.5 (0.3, 0.8)
Ohio 2 122.8 (120.2, 125.4) 22 (11, 33) 9,439 rising rising trend 0.7 (0.5, 1.6)
Maine 2 122.8 (115.5, 130.4) 23 (2, 43) 1,245 stable stable trend 0.6 (-0.9, 2.2)
District of Columbia 2 122.4 (111.2, 134.4) 24 (1, 48) 460 stable stable trend -0.5 (-1.4, 0.5)
Alabama 2 122.0 (118.0, 126.0) 25 (9, 36) 3,959 rising rising trend 0.4 (0.1, 0.8)
Virginia 2 121.0 (118.0, 124.1) 26 (13, 37) 6,513 stable stable trend 0.3 (0.0, 0.6)
Pennsylvania 2 120.8 (118.3, 123.3) 27 (16, 36) 10,493 rising rising trend 0.5 (0.3, 0.6)
Colorado 2 120.7 (116.9, 124.5) 28 (12, 39) 4,083 stable stable trend 0.5 (-0.4, 1.8)
South Carolina 2 120.3 (116.5, 124.2) 29 (12, 39) 4,240 rising rising trend 0.5 (0.3, 0.7)
Louisiana 7 119.9 (115.8, 124.1) 30 (12, 41) 3,526 rising rising trend 0.9 (0.6, 1.4)
Wyoming 2 119.6 (107.7, 132.5) 31 (1, 49) 411 stable stable trend 0.3 (-3.2, 3.3)
Montana 2 119.6 (111.1, 128.7) 32 (2, 47) 833 stable stable trend 2.5 (-2.1, 6.4)
Kentucky 7 118.7 (114.5, 122.9) 33 (15, 43) 3,377 rising rising trend 0.6 (0.4, 0.8)
South Dakota 2 117.1 (107.4, 127.4) 34 (3, 48) 613 stable stable trend 0.2 (-0.6, 0.9)
Tennessee 2 116.8 (113.5, 120.1) 35 (24, 44) 5,252 rising rising trend 0.4 (0.1, 0.7)
Oregon 2 116.1 (111.9, 120.4) 36 (22, 46) 3,210 rising rising trend 2.5 (0.4, 3.8)
North Dakota 2 115.1 (104.5, 126.4) 37 (3, 49) 488 rising rising trend 0.6 (0.2, 1.1)
Florida 2 114.9 (113.1, 116.7) 38 (32, 44) 17,874 rising rising trend 0.5 (0.4, 0.7)
Alaska 2 114.4 (103.5, 126.1) 39 (4, 49) 437 stable stable trend 3.0 (-0.5, 5.3)
Michigan 2 114.4 (111.6, 117.1) 40 (30, 46) 7,439 stable stable trend 0.2 (-0.1, 1.1)
Oklahoma 2 114.0 (109.6, 118.5) 41 (27, 47) 2,756 stable stable trend -0.3 (-1.3, 0.5)
Mississippi 2 113.8 (108.8, 118.9) 42 (25, 48) 2,141 rising rising trend 0.8 (0.4, 1.1)
Utah 7 113.3 (108.0, 118.9) 43 (24, 48) 1,728 stable stable trend 0.3 (-0.1, 1.8)
Arkansas 2 113.0 (108.1, 118.1) 44 (27, 48) 2,207 rising rising trend 1.0 (0.5, 2.8)
California 7 111.5 (110.1, 112.9) 45 (39, 47) 25,819 stable stable trend 0.1 (-0.1, 0.5)
West Virginia 2 110.8 (104.8, 117.1) 46 (29, 49) 1,438 stable stable trend 0.9 (-0.3, 2.6)
Texas 7 109.5 (107.9, 111.2) 47 (41, 48) 17,580 rising rising trend 1.9 (0.8, 2.9)
New Mexico 7 103.1 (97.5, 108.9) 48 (43, 49) 1,409 stable stable trend 0.4 (-0.2, 2.3)
Arizona 2 102.6 (99.6, 105.7) 49 (46, 49) 4,909 stable stable trend 0.1 (-0.2, 0.4)
Puerto Rico 2 89.1 (85.1, 93.2) N/A 2,166 rising rising trend 2.6 (0.4, 4.8)
Indiana 2
data not available
N/A
data not available
data not available
data not available
Nevada 2
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2024 9:54 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
2 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
4 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top